Activity of dual SRC-ABL inhibitors highlights the role of BCR/ABL kinase dynamics in drug resistance.

Venue / Journal

Proc Natl Acad Sci U S A

Date

Tue, 06/13/2006 - 12:00

Additional Journal Information

103(24):9244-9

Authors

Azam M, Nardi V, Shakespeare WC, Metcalf CA, Bohacek RS, Wang Y, Sundaramoorthi R, Sliz P, Veach DR, Bornmann WG, Clarkson B, Dalgarno DC, Sawyer TK, Daley GQ.

Pubmed URL

http://www.ncbi.nlm.nih.gov/pubmed/16754879